Cell Therapeutics Inc (CTIC): Cell Therapeutics: Solid Pipeline, Partnerships ... Seeking Alpha Furthermore, Pixuvri is also in Phase III (PIX306) in combination with rituximab, for aggressive NHL or grade 3 lymphoma patients who are not eligible for stem cell transplant and have relapsed after therapy. Pacritinib is an oral selective tyrosine ... |
